Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
New Microbes New Infect ; 7: 100-4, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26442153

ABSTRACT

Bacterial bloodstream infections (BSI) account for considerable morbidity worldwide, but epidemiological data from resource-constrained tropical settings are scarce. We analysed 293 blood cultures from patients presenting to a regional referral hospital in Bouaké, central Côte d'Ivoire, to determine the aetiology of community-onset BSI. The prevalence of bacteraemia was 22.5%, with children being most commonly affected. Enterobacteriaceae (predominantly Klebsiella pneumoniae and Salmonella enterica) accounted for 94% of BSI. Staphylococcus aureus was the only relevant Gram-positive pathogen. Clinical signs and symptoms were not significantly associated with blood culture positivity after controlling for malaria.

2.
HIV Med ; 14(3): 182-6, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22805116

ABSTRACT

OBJECTIVES: The aim of the study was to determine the aetiology and clinical predictors of peripheral lymphadenopathy in HIV-infected individuals during the antiretroviral (ARV) era in a nontuberculosis endemic setting. METHODS: A multicentred, retrospective cohort study of peripheral lymph node biopsies in HIV-positive adults was carried out. A total of 107 charts were identified and reviewed for clinical features, lymphadenopathy size, and ARV use and duration. Biopsy results were categorized, and multivariate logistic regression determined independent predictors of lymphadenopathy aetiology. RESULTS: Evaluation of 107 peripheral lymph node biopsies revealed that 42.9% of peripheral lymphadenopathy was attributable to malignancy, 49.5% to reactive changes, and 7.5% to infections, with only 2.8% of all cases secondary to tuberculosis. Fevers, weight loss, ARV use, and lower viral loads are significantly associated with nonreactive lymphadenopathy. CONCLUSIONS: Lymphadenopathy is likely to be reactive or malignant in nontuberculosis endemic regions. Readily available clinical features can aid clinicians in predicting the underlying aetiology, those at risk for malignancy, and who to biopsy.


Subject(s)
AIDS-Related Complex/etiology , AIDS-Related Opportunistic Infections/etiology , Acquired Immunodeficiency Syndrome/complications , HIV Seropositivity/complications , Lymph Nodes/pathology , Lymphatic Diseases/etiology , AIDS-Related Complex/epidemiology , AIDS-Related Complex/pathology , AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/pathology , Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/pathology , Adult , Biopsy , Boston/epidemiology , CD4 Lymphocyte Count , Cohort Studies , Female , HIV Seropositivity/epidemiology , HIV Seropositivity/pathology , Humans , Logistic Models , Lymphatic Diseases/pathology , Lymphoma, Non-Hodgkin/epidemiology , Male , Middle Aged , Mycobacterium avium-intracellulare Infection/epidemiology , Retrospective Studies , Sarcoma, Kaposi/epidemiology , Syphilis/epidemiology , Tuberculosis, Lymph Node/epidemiology , Viral Load
SELECTION OF CITATIONS
SEARCH DETAIL